Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) EBT Margin (2016 - 2026)

Champions Oncology (CSBR) has 16 years of EBT Margin data on record, last reported at 1.7% in Q4 2025.

  • For Q4 2025, EBT Margin fell 378.0% year-over-year to 1.7%; the TTM value through Oct 2025 reached 4.03%, up 522.0%, while the annual FY2025 figure was 8.12%, 2269.0% up from the prior year.
  • EBT Margin reached 1.7% in Q4 2025 per CSBR's latest filing, up from 3.23% in the prior quarter.
  • Across five years, EBT Margin topped out at 26.52% in Q1 2025 and bottomed at 20.96% in Q1 2024.
  • Average EBT Margin over 5 years is 3.37%, with a median of 1.8% recorded in 2021.
  • Peak YoY movement for EBT Margin: plummeted -2501bps in 2023, then skyrocketed 4747bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 2.45% in 2021, then crashed by -101bps to 0.01% in 2022, then plummeted by -127001bps to 17.8% in 2023, then surged by 131bps to 5.48% in 2024, then crashed by -69bps to 1.7% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 1.7% in Q4 2025, 3.23% in Q3 2025, and 15.9% in Q2 2025.